Register now or log in to join your professional community.
You do not expect too many defects to be found in this additional testing and the cost associated due to any defects leaked would not be more that US$. You:
A. Should not proceed as the Cost-benefit analysis does not favour the additional round of testing
B. Should conduct the tests as planned
C. Are going against the tenants of Quality Management
D. Should continue testing as long as you find even a single defect
Thanks for the invitation, I think A is the good answer
A. Should not proceed as the Cost-benefit analysis does not favour the additional round of testing
thanks for invition ,,,,,,,,,, my choice is option A
Thanks for the invitation Mr. Farooq; another good question put forth by you.
I fully endorse answers given by Experts/Colleagues.
Eventhough A and C both are closely related to the right answer, I would go with answer A, cost-benefit analysis does not favour additional testing